PS Ratio
N/A
Fri, 29 Nov 2024 21:58:05 GMT
Summary:
CRISPR Therapeutics AG price to sales ratio is not available.CRSP PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | -0.4% | -0.4% | - |
| 1 m1 month | - | +4.3% | +4.3% | - |
| 3 m3 months | - | +5.6% | +5.9% | - |
| 6 m6 months | - | -4.3% | -3.8% | - |
| ytdytd | - | -19.1% | -13.7% | - |
| 1 y1 year | - | -26.6% | -21.1% | - |
| 5 y5 years | - | -29.1% | +0.1% | - |
CRSP PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | 20.31 | 12.58 | ||
| 3 y | 3 years | 10.08 K | 3.67 | ||
| 5 y | 5 years | 28.59 K | 3.67 | ||
| alltime | all time | 28.59 K | 3.67 |
CRISPR Therapeutics AG PS Ratio History
| Date | Value |
|---|---|
| 2023 | 13.58(-99.8%) |
| 2022 | 7523.51(>+9900.0%) |
| 2021 | 6.39(-100.0%) |
| 2020 | 20.84 K(>+9900.0%) |
| Date | Value |
|---|---|
| 2019 | 12.78(-97.3%) |
| 2018 | 474.21(+1939.6%) |
| 2017 | 23.25(-85.1%) |
| 2016 | 155.83 |
FAQ
- What is the all time high PS ratio for CRISPR Therapeutics AG?
What is the all time high PS ratio for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high price to sales ratio is 28.59 K